Labcorp to buy Opko unit's cancer test assets for up to $225M | MedTech Dive

Retrieved on: 2025-03-12 15:59:00

Tags for this article:

Burlington, North Carolina

LabCorp

Click the tags to see associated articles and topics

Labcorp to buy Opko unit's cancer test assets for up to $225M | MedTech Dive. View article details on hiswai:

Summary

The article discusses LabCorp's acquisition of BioReference Health's oncology diagnostics from OPKO Health for up to $225 million, expanding its MedTech portfolio. This move aligns with LabCorp's strategy in Burlington, North Carolina, to enhance cancer care services. Tags like Microarrays, INVITAE, and Phillip Frost connect to the broader MedTech and clinical testing landscape.

Article found on: www.medtechdive.com

View Original Article